PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss
Authors
Keywords
PPARG, SOST/sclerostin, PPRE, Bone mass, Marrow adipocytes
Journal
BONE
Volume 147, Issue -, Pages 115913
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.bone.2021.115913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
- (2020) Kenneth G Saag et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
- (2020) Hiroshi Kawaguchi JOURNAL OF BONE AND MINERAL RESEARCH
- The role of osteoblasts in energy homeostasis
- (2019) Naomi Dirckx et al. Nature Reviews Endocrinology
- Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development
- (2018) Cristal S Yee et al. JOURNAL OF BONE AND MINERAL RESEARCH
- SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury
- (2018) Jiun C Chang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TIEG and estrogen modulate SOST expression in the murine skeleton
- (2017) Malayannan Subramaniam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis
- (2017) Heather Fairfield et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Marrow Adipose Tissue: Skeletal Location, Sexual Dimorphism, and Response to Sex Steroid Deficiency
- (2017) Beata Lecka-Czernik et al. Frontiers in Endocrinology
- Bone marrow adipocytes
- (2017) Mark C. Horowitz et al. Adipocyte
- Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights
- (2016) Smriti Murali Krishna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone
- (2016) Flor M. Pérez-Campo et al. CALCIFIED TISSUE INTERNATIONAL
- Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
- (2016) Mayumi Ukita et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D 3 or TGFβ 1 responsiveness
- (2016) Hillary C. St. John et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation
- (2016) Wei Zou et al. NATURE MEDICINE
- Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction
- (2016) Corinna Wehmeyer et al. Science Translational Medicine
- PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption
- (2016) L.A. Stechschulte et al. EBioMedicine
- Zinc finger protein 467 regulates Wnt signaling by modulating the expression of sclerostin in adipose derived stem cells
- (2015) Li You et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
- (2015) Marc N Wein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- 1α,25-dihydroxyvitamin D 3 stimulates human SOST gene expression and sclerostin secretion
- (2015) Asiri R. Wijenayaka et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues
- (2015) Erica L. Scheller et al. Nature Communications
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
- (2013) Vincent M Brandenburg et al. BMC Nephrology
- Coronary artery wall imaging in mice using osmium tetroxide and micro-computed tomography (micro-CT)
- (2012) Vinay M. Pai et al. JOURNAL OF ANATOMY
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
- (2012) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels
- (2012) Sandra Jastrzebski et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism
- (2011) William P. Cawthorn et al. BONE
- The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
- (2011) Dongxing Zhu et al. PLoS One
- Sclerostin is a direct target of osteoblast-specific transcription factor osterix
- (2010) Fan Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression
- (2010) G. Mabilleau et al. DIABETIC MEDICINE
- Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
- (2010) Mary L Bouxsein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteocyte Wnt/ -Catenin Signaling Is Required for Normal Bone Homeostasis
- (2010) I. Kramer et al. MOLECULAR AND CELLULAR BIOLOGY
- PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells
- (2009) Keith R. Shockley et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women
- (2008) F. A. Syed et al. OSTEOPOROSIS INTERNATIONAL
- PPARγand Apoptosis in Cancer
- (2008) Heath A. Elrod et al. PPAR Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation